Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and

Remi Neviere1,2, Yichi Yu3,4, Lei Wang3,4

  • 1Department of Physiology, School of Medicine, Pole Recherche 1, place de Verdun, 59045, Lille Cedex, France. rneviere@univ-lille2.fr.

Insights

Advanced glycation end products (AGEs) contribute to cardiovascular diseases by causing oxidative stress and inflammation. This review explores how AGEs impact heart function, focusing on AGE-induced mitochondrial dysfunction.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Disorders
  • Molecular Medicine

Background:

  • Advanced glycation end products (AGEs) are formed via non-enzymatic sugar reactions with proteins, lipids, and nucleic acids.
  • Both endogenous formation and dietary intake contribute to AGE accumulation.
  • AGEs impact cardiac cell structure and function, promoting cardiovascular disease progression.

Purpose of the Study:

  • To review the role of AGEs in cardiovascular disease development and progression.
  • To elucidate the mechanisms by which AGEs induce oxidative stress and inflammation in cardiac cells.
  • To highlight AGE-induced mitochondrial dysfunction in the myocardium as a key factor in heart failure.

Main Methods:

  • Literature review of studies on AGEs, RAGE signaling, oxidative stress, inflammation, and cardiovascular disorders.
  • Analysis of molecular mechanisms linking AGEs to cellular dysfunction.
  • Focus on AGEs' impact on mitochondrial function in cardiomyocytes.

Main Results:

  • AGEs induce oxidative stress and inflammation via receptor for advanced glycation end products (RAGE) activation.
  • RAGE activation upregulates nuclear factor-κB, promoting inflammatory and fibrotic responses.
  • AGE accumulation disrupts cardiac cell structure and function, contributing to microvascular and macrovascular complications.

Conclusions:

  • AGEs are significant contributors to cardiovascular disease pathogenesis.
  • Targeting AGEs and RAGE pathways may offer therapeutic strategies for cardiovascular disorders.
  • AGE-induced mitochondrial dysfunction is a critical mechanism underlying heart failure.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
550
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.2K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.7K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.8K